- Home
- EDSA vs PPBT Comparison
EDSA vs PPBT Comparison
Compare EDSA & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- PPBT
- Stock Information
- Founded
- EDSA 2015
- PPBT 2010
- Country
- EDSA Canada
- PPBT Israel
- Employees
- EDSA N/A
- PPBT N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- EDSA Health Care
- PPBT Health Care
- Exchange
- EDSA Nasdaq
- PPBT Nasdaq
- Market Cap
- EDSA 11.0M
- PPBT 9.2M
- IPO Year
- EDSA N/A
- PPBT N/A
- Fundamental
- Price
- EDSA $2.09
- PPBT $2.51
- Analyst Decision
- EDSA Strong Buy
- PPBT Strong Buy
- Analyst Count
- EDSA 1
- PPBT 2
- Target Price
- EDSA $21.00
- PPBT $126.50
- AVG Volume (30 Days)
- EDSA 50.3K
- PPBT 62.2K
- Earning Date
- EDSA 12-13-2024
- PPBT 11-15-2024
- Dividend Yield
- EDSA N/A
- PPBT N/A
- EPS Growth
- EDSA N/A
- PPBT N/A
- EPS
- EDSA N/A
- PPBT N/A
- Revenue
- EDSA N/A
- PPBT N/A
- Revenue This Year
- EDSA N/A
- PPBT N/A
- Revenue Next Year
- EDSA N/A
- PPBT N/A
- P/E Ratio
- EDSA N/A
- PPBT N/A
- Revenue Growth
- EDSA N/A
- PPBT N/A
- 52 Week Low
- EDSA $2.09
- PPBT $2.43
- 52 Week High
- EDSA $6.46
- PPBT $23.20
- Technical
- Relative Strength Index (RSI)
- EDSA 19.32
- PPBT 28.04
- Support Level
- EDSA $2.26
- PPBT $2.50
- Resistance Level
- EDSA $2.44
- PPBT $2.82
- Average True Range (ATR)
- EDSA 0.26
- PPBT 0.38
- MACD
- EDSA -0.06
- PPBT 0.04
- Stochastic Oscillator
- EDSA 0.00
- PPBT 5.10
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.